Happy New Year Advocates! 2021 ended with some amazing accomplishments thanks to your hard work. You may have been in legislative meetings, sent emails or simply shared your story with someone who did not know about ataxia. Every action, whether big or small, helps to raise awareness of FA and the resources needed to expedite treatments! Here are just a few highlights of what our community successfully undertook together:

74,000 people signed a petition asking the FDA and Reata Pharmaceutics to move forward on a New Drug Application (NDA) for Omaveloxolone - that NDA submission is expected to be filed in the first quarter of 2022.

Read the Full Advocacy Newsletter